3. UnitedHealth Group Incorporated (NYSE: UNH)
Number of Hedge Fund Holders: 89
Number of Years of Consecutive Dividend Increases: 12
Dividend Yield: 1.2%
UnitedHealth Group Incorporated (NYSE: UNH) is an American healthcare company that operates through its UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx segments to offer a range of healthcare products and services. The company ranks 3rd on our list of stocks with over 10 years of dividend increases.
Raymond James’ John Ransom has reiterated his Strong Buy rating UnitedHealth Group Incorporated (NYSE: UNH) shares while raising his price target from $435 to $515 just this July. The development came in light of stronger Q2 results on UnitedHealth Group Incorporated’s (NYSE: UNH) part than expected, Ransom commented.
In the second quarter of 2021, UnitedHealth Group Incorporated (NYSE: UNH) had an EPS of $4.70, beating estimates by $0.24. The company’s revenue was $71.32 billion, up 14.78% year over year and also beating estimates by $1.77 billion. UnitedHealth Group Incorporated (NYSE: UNH) has gained about 19.30% in the past 6 months and 18.64% year to date as well.
By the end of the first quarter of 2021, 89 hedge funds out of the 866 tracked by Insider Monkey held stakes in UnitedHealth Group Incorporated (NYSE: UNH) worth roughly $12.09 billion. This is compared to 91 hedge funds in the previous quarter with stakes worth approximately $10.7 billion.
ClearBridge Investments, an investment management firm, mentioned UnitedHealth Group Incorporated (NYSE: UNH) in its second-quarter 2021 investor letter. Here’s what they said:
“A good way to conceptualize how we think about portfolio construction is to picture a pyramid. At the bottom of the pyramid are the durable compounding growth companies that form the strong foundation, resilience and consistency for the Strategy. We think these companies should comprise just under half of portfolio assets and feature annual revenue growth rates ranging from two times GDP up to 20% as well as healthy free cash flow generation.
UnitedHealth Group, a name we have owned in the Strategy since 1992, is a good example of a long-term compounder, having grown its revenue base from approximately $600 million to north of $260 billion over that time frame. It remains constantly focused on investing in new growth drivers such as telemedicine and health care analytics. Broadcom and Comcast have delivered similar long-term appreciation through a combination of organic growth, capital deployment into new and adjacent opportunities through merger and acquisition activity as well as returning capital to shareholders through buybacks and dividends.”
